# A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

> **NCT04776993** · PHASE3 · UNKNOWN · sponsor: **University of Pisa** · enrollment: 52 (estimated)

## Conditions studied

- Graves' Orbitopathy

## Interventions

- **DRUG:** Methimazole
- **PROCEDURE:** Radioiodine or thyroidectomy

## Key facts

- **NCT ID:** NCT04776993
- **Lead sponsor:** University of Pisa
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-02
- **Primary completion:** 2024-09-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776993, "A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04776993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*